Showing results (3161-3170 of 4,783) with videos related to

Sort By:
Pageof 479
Drug Discovery Today|July 7, 2022
Targeting microglia-oligodendrocyte crosstalk in neurodegenerative and psychiatric disordersReza Rahimian, Kelly Perlman, Candice Canonne, et al.
Drug Discovery Today|May 28, 2021
High-throughput screening assays for SARS-CoV-2 drug development: Current status and future directionsTuan Xu, Wei Zheng, Ruili Huang
Drug Discovery Today|May 31, 2021
Stimulus-responsive liposomes for biomedical applicationsAntonia I Antoniou, Sabrina Giofrè, Pierfausto Seneci, et al.
Drug Discovery Today|July 6, 2021
Systematic risk identification and assessment using a new risk map in pharmaceutical R&DAlexander Schuhmacher, Clara Brieke, Oliver Gassmann, et al.
Drug Discovery Today|June 16, 2022
BCL2 G quadruplex-binding small molecules: Current status and prospects for the development of next-generation anticancer therapeuticsMamta Singh, Rajat Gupta, Lucia Comez, et al.
Drug Discovery Today|July 5, 2021
IFN-α: A key therapeutic target for multiple autoimmune rheumatic diseasesFrédéric De Ceuninck, Fanny Duguet, Audrey Aussy, et al.
Drug Discovery Today|July 5, 2021
Duocarmycin-based antibody-drug conjugates as an emerging biotherapeutic entity for targeted cancer therapy: Pharmaceutical strategy and clinical progressHang-Ping Yao, Hui Zhao, Rachel Hudson, et al.
Drug Discovery Today|September 18, 2020
Therapeutic agents for targeting desmoplasia: current status and emerging trendsTania Nandi, Sai Pradyuth, Arihant Kumar Singh, et al.
Drug Discovery Today|September 18, 2020
The E2 ubiquitin-conjugating enzyme UbcH5c: an emerging target in cancer and immune disordersYuan Zhou, Runzhe Chen, Xiaofang Luo, et al.
Drug Discovery Today|September 19, 2020
Gene therapy in solid tumors: trends in trials in China and beyondKun Chen, Shuhang Wang, Bin Chen, et al.
Pageof 479